Ramsay Health Care Limited: One share to buy and hold for the next decade

Will this healthcare stock record high total returns?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Ramsay Health Care Limited (ASX: RHC) has a mix of defensive characteristics and growth prospects which have caused its shares to rise by 21% in the last year. This is ahead of sector peer CSL Limited (ASX: CSL) and the ASX, which are up 18% and 3% respectively. Further capital gains are ahead for Ramsay in my view due to its demographic tailwind, acquisition potential and expansion strategy.

Demographics

Over 10% of the world's population is now aged over 65 years. Further, the number of people aged over 60 is forecast to more than triple by 2050. This means that there is a large and rapidly growing target market for Ramsay, since chronic diseases are more prevalent with older age. Allied to this is an increase in therapeutic innovations, such as new technology, which will increase demand for hospital treatment.

Ramsay is well-placed to benefit from this demographic tailwind. It has exposure to three key markets (Australia, France and the UK) where an ageing population means that demand for healthcare is rising. Growing pressure on public healthcare systems means that there is rising demand for private healthcare specifically, with private health insurance membership in Australia now at 47.2% and increasing.

Acquisition potential

Ramsay has a proven operating model which has been able to successfully integrate multiple acquisitions. Looking ahead, it is set to be active in the M&A space and its financial standing provides the flexibility for it to do so. For example, Ramsay's free cash flow has averaged $288 million over the last two financial years, while its interest repayments of $126 million were covered over 6 times by operating profit last year.

This indicates that Ramsay can increase borrowings to fund further acquisitions. Although its joint venture in China failed, it has identified Asia as a key growth area for the long term. For example, China and India have the highest number of diabetics in the world, while its established presence in Malaysia and Indonesia provides a platform for growth in the region.

Expansion strategy

Ramsay's brownfield development strategy is driven by unmet demand. It plans to open 400 beds and 12 operating theatres in the 2016 calendar year which will cost as much as $197 million. This strategy is sound because it involves multiple smaller developments which allow Ramsay to become geographically diversified. This reduces the company's risk profile, but also enables Ramsay to implement incremental technological advances to gain a competitive advantage over its rivals in what is an increasingly competitive private healthcare space.

Although Ramsay has a P/E ratio of 32, this is lower than healthcare sector peer Cochlear Limited (ASX: RHC). It has a P/E ratio of 40. Due to Ramsay's expansion strategy, demographic tailwind and acquisition potential, it would be unsurprising for its shares to move higher in the long run.

Motley Fool contributor Robert Stephens has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »